Table 3.
Plasma parameters measured at 0-weeks and at 15-weeks resistance training (RT).
| Control (n = 29) | p | All-RT (n = 26) | p | Compliant-RT (n = 15) | p | ||||
|---|---|---|---|---|---|---|---|---|---|
| Week-0 | Week-15 | Week-0 | Week-15 | Week-0 | Week-15 | ||||
| Adiponectin (µg/mL)† | 40.6 (38.1) | 34.1 (46.7) | 0.24 | 34.3 (37.8) | 27.9 (34.4) | < 0.001*** | 36.4 (45.1) | 21.0 (35.2) | < 0.001*** |
| Adipsin (µg/mL) | 3.5 (0.9) | 3.8 (0.78) | 0.37 | 3.7 (0.7) | 3.6 (0.9) | 0.07 | 3.8 (0.9) | 3.7 (0.9) | 0.28 |
| BDNF (ng/mL)† | 1.4 (2.8) | 1.4 (2.4) | 0.96 | 2.1 (2.2) | 1.5 (3.4) | 0.52 | 1.4 (2.1) | 1.5 (1.2) | 0.54 |
| CRP (µg/mL) | 9.4 (16.4) | 8.7 (15.5) | 0.76 | 9.1 (12.4) | 8.6 (12.1) | 1.00 | 11.5 (13.4) | 9.3 (12.4) | 0.39 |
| Leptin (ng/mL)† | 26.2 (33.8) | 25.4 (28.7) | 0.61 | 31.7 (23.1) | 29.2 (25.3) | 0.17 | 32.2 (22.1) | 31.5 (19.7) | 0.36 |
| Lipocalin-2 (µg/mL) | 96.3 (52.9) | 93.8 (33.1) | 0.14 | 89.0 (25.0) | 84.4 (20.5) | 0.03* | 95.2 (26.4) | 84.3 (20.0) | < 0.01** |
| MCP-1 (pg/mL) | 312.0 (115.5) | 345.8 (117.1) | 0.02* | 302.5 (160.5) | 292.7 (173.7) | 0.22 | 279.5 (153.7) | 262.5 (166.1) | 0.21 |
| MMP-2 (ng/mL) | 127.2 (38.3) | 118.9 (32.7) | 0.66 | 118.6 (20.1) | 113.1 (29.8) | 0.36 | 126.3 (17.9) | 123.9 (27.3) | 0.25 |
| MMP-9 (ng/mL) | 39.7 (18.5) | 35.5 (21.4) | 0.24 | 30.4 (29.9) | 28.4 (18.6) | 0.36 | 38.2 (30.3) | 26.8 (19.9) | 0.11 |
| Osteonectin (pg/mL)† | 343.9 (242.0) | 334.3 (242.2) | 0.67 | 370.4 (164.0) | 343.9 (168.3) | 0.99 | 332.9 (186.9) | 310.0 (130.7) | 0.39 |
| PAI-1 (ng/mL) | 34.6 (19.9) | 39.3 (32.1) | 0.74 | 32.8 (16.6) | 28.2 (28.1) | 0.19 | 30.3 (10.7) | 26.6 (20.6) | 0.30 |
| Resistin (ng/mL) | 27.5 (13.4) | 25.5 (14.4) | 0.29 | 25.5 (9.8) | 24.4 (10.9) | 0.07 | 26.8 (9.7) | 25.2 (10.1) | 0.04* |
| SHBG (nM) | 81.1 (42.5) | 76.8 (45.8) | 0.41 | 86.0 (33.7) | 88.9 (34.0) | 0.14 | 72.8 (40.0) | 84.5 (33.9) | 0.08 |
| Testosterone (ng/mL) | 0.8 (0.3) | 0.8 (0.3) | 0.53 | 0.7 (0.2) | 0.8 (0.2) | 0.04* | 0.8 (0.4) | 0.8 (0.2) | 0.05* |
| Testosterone/SHBG (%) | 3.9 (3.5) | 3.9 (3.8) | 0.85 | 3.2 (2.3) | 3.6 (2.1) | 0.59 | 3.6 (1.8) | 3.7 (2.1) | 0.89 |
| TNFα (pg/mL) | 30.4 (31.8) | 35.9 (31.9) | 0.73 | 34.3 (28.1) | 32.6 (34.3) | 0.40 | 32.6 (27.11) | 33.7 (18.6) | 0.67 |
Data presented as Median (IQR = Q3–Q1). Significance *p ≤ 0.05, **p < 0.01, ***p < 0.001.
Wilcoxon-signed rank tests was used to compare measured parameters within each study group across the 15-week study period.
Testosterone unit conversion factor: nmol/L = ng/mL × 3.48.
BDNF brain derived neurotropic factor, CRP-C reactive protein, MCP monocyte chemoattractant protein, MMP matrix metalloproteinase, PAI plasminogen activator inhibitor, SHBG sex hormone binding globulin, TNF tumour necrosis factor.
†Different numbers due to limits-of-detection: Adiponectin—Control (n = 21), All-RT (n = 23), Compliant-RT (n = 14); BDNF—Control (n = 26), All-RT (n = 25), Compliant-RT (n = 14); Leptin—Control (n = 27); Osteonectin—Control (n = 26), All-RT (n = 25), Compliant-RT (n = 14).